Some Analysts Just Cut Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Estimates [Yahoo! Finance]
Harvard Bioscience, Inc. (HBIO)
Last harvard bioscience, inc. earnings: 2/26 07:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.harvardbioscience.com
Company Research
Source: Yahoo! Finance
Revenue estimates were cut sharply as the analysts signalled a weaker outlook - perhaps a sign that investors should temper their expectations as well. Following the latest downgrade, the dual analysts covering Harvard Bioscience provided consensus estimates of US$99m revenue in 2024, which would reflect a perceptible 2.5% decline on its sales over the past 12 months. Before the latest update, the analysts were foreseeing US$113m of revenue in 2024. It looks like forecasts have become a fair bit less optimistic on Harvard Bioscience, given the substantial drop in revenue estimates. See our latest analysis for Harvard Bioscience Notably, the analysts have cut their price target 11% to US$6.25, suggesting concerns around Harvard Bioscience's valuation. Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. Over the past five years, revenues have declined around
Show less
Read more
Impact Snapshot
Event Time:
HBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HBIO alerts
High impacting Harvard Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
HBIO
News
- Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual MeetingGlobeNewswire
- Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual ConferenceGlobeNewswire
- Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 50% Below Their Intrinsic Value Estimate [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Harvard Bioscience Announces Second Quarter 2024 Financial ResultsGlobeNewswire
HBIO
Earnings
- 8/8/24 - Miss
HBIO
Sec Filings
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- HBIO's page on the SEC website